A Novel Predictive Model of Outcome in Acute Myeloid Leukemia Without Favorable Karyotype Based on Treatment Strategy, Karyotype and FLT3-ITD Mutational Status

American Journal of Hematology - United States
doi 10.1002/ajh.25290
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

DOCK2: A Novel FLT3/ITD Leukemia Drug Target

Oncotarget
Oncology
2017English

Acute Myeloid Leukemia With Near-Triploid Karyotype and Extramedullary Involvement of Mediastinum

Bone Marrow Transplantation
TransplantationHematology
2005English

Examination of the FLT3 and NPM1 Mutational Status in Patients With Acute Myeloid Leukemia From Southeastern Poland

Archives of Medical Science
Medicine
2016English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

FLT3 Mutations in Normal Karyotype Acute Myeloid Leukemia in First Complete Remission Treated With Autologous Peripheral Blood Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2005English

Synergistic Cell Death in FLT3-ITD Positive Acute Myeloid Leukemia by Combined Treatment With Metformin and 6-Benzylthioinosine

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy